Clinical Trial: A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07217067) titled 'A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation' on Oct. 14.

Brief Summary: A randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillaiton

Study Start Date: Oct. 31

Study Type: INTERVENTIONAL

Condition: Atrial Fibrillation

Intervention: DRUG: PKN605

PKN605 is an oral formulation

OTHER: Placebo

Matching placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: N...